News

10/23/2011Meet Sovicell at AAPS in Washington DC at joint booth with ADMEcell10/17/2011Sovicell will present a poster on “TRANSIL High Sensitivity Binding Assay: 9/20/2011Sovicell will be attending Agilent Technologies’ Automation User Group Meeting in San Francisco, California, which is being held from September 20th to 22nd. 9/19/2011Sovicell will be attending the 2nd World Conference on Physico-Chemical Methods in Drug Discovery and Development in Zadar, Croatia, which is being held from September 19th to 22nd.

Contract Research Services

Sovicell’s experienced team offers state-of-the-art services for drug development which includes access to all of our products, on a fee-for-service basis. Our TRANSIL technology platform and SOVICYTE cells and cell culture products enable us to reliably assess the in vitro ADMET profiles of pharmaceutical drug candidates. Major pharmaceutical companies have adopted our TRANSIL technology and we are continually developing services in collaboration with our customers to meet their needs.

The most recent additions to our services include a blood-to-brain absorption test that is based on true biological membranes and is proving invaluable in CNS drug research and development, as well as highlighting side effects in other therapeutic areas.

The Sovicell service advantage:

tailor made services; customized to our customers’ needs
responsive, timely and professional delivery of results including presentation & interpretation
state-of-the-art technology, methods and equipment
experienced and knowledgeable staff

To find out further information or to receive advice about your specific needs, please contact our dedicated contract research team: service@sovicell.com.